Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol and alopecia.

R J Hilder

    Cutis
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Propranolol use can cause telogen effluvium alopecia. This hair loss type, observed in two cases, may serve as a diagnostic indicator for this medication side effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sarcoidosis with cutaneous lesions localized to the dorsum of the feet. A case report.

    Archives of dermatology·1979
    Same journal

    A Solitary Axillary Subcutaneous Mass.

    Cutis·2026
    Same journal

    Microcystic Adnexal Carcinoma-like Neoplasm in a Patient With POT1 Mutation.

    Cutis·2026
    Same journal

    A Hybrid Suture Technique: Suture Modification With Dental Roll Insertion.

    Cutis·2026
    Same journal

    Beyond Conventional Paradigms: Rethinking the Evaluation and Management of Melasma.

    Cutis·2026
    Same journal

    Social Drivers of Health Curriculum for Dermatology Residents: the UCSF Experience.

    Cutis·2026
    Same journal

    Hospital Dermatology: Review of Research in 2024-2025.

    Cutis·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Alopecia is a common dermatological condition with various etiologies.
    • Beta-blockers, such as propranolol, are widely prescribed for cardiovascular conditions.
    • Drug-induced hair loss is a recognized but often underreported adverse effect.

    Observation:

    • A case of alopecia developing in a patient undergoing propranolol treatment is presented.
    • The patient experienced hair loss consistent with telogen effluvium.
    • This case is compared to a previously reported instance of propranolol-associated alopecia.

    Findings:

    • Both reported cases of propranolol-induced alopecia exhibited a telogen effluvium pattern.
    • Telogen effluvium is characterized by diffuse shedding of resting (telogen) phase hairs.

    Related Experiment Videos

  • This specific hair loss pattern may be a key diagnostic feature.

    • Implications:

    • The findings suggest that telogen effluvium could be a specific indicator of propranolol-induced alopecia.
    • Current major medical textbooks do not widely document this propranolol side effect.
    • Increased awareness among healthcare practitioners is crucial for accurate diagnosis and patient management.